Clover Health Investments Corp
NASDAQ:CLOV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Astera Labs Inc
NASDAQ:ALAB
|
US |
|
Tokyo Board Industries Co Ltd
TSE:7815
|
JP |
|
Macro Enterprises Inc
XTSX:MCR
|
CA |
|
Everi Holdings Inc
NYSE:EVRI
|
US |
|
ReGen III Corp
XTSX:GIII
|
CA |
|
Kellogg Co
NYSE:K
|
US |
|
Global Payments Inc
NYSE:GPN
|
US |
|
Fisker Inc
OTC:FSRNQ
|
US |
|
S
|
Silver Spike Investment Corp
NASDAQ:SSIC
|
US |
|
K
|
Kiwibox.com Inc
OTC:KIWB
|
US |
|
Chongqing Sansheng Industrial Co Ltd
SZSE:002742
|
CN |
|
G
|
Gansu Guofang Industry & Trade Group Ltd by Share Ltd
SSE:601086
|
CN |
|
A
|
Anhui Wanwei Updated High-tech Material Industry Co Ltd
SSE:600063
|
CN |
|
A
|
Alco Holdings Ltd
HKEX:328
|
HK |
|
Anritsu Corp
OTC:AITUF
|
JP |
|
Lithium Argentina AG
NYSE:LAR
|
CH |
|
VETO Switch Gears And Cables Ltd
NSE:VETO
|
IN |
Clover Health Investments Corp
Total Liabilities & Equity
Clover Health Investments Corp
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Clover Health Investments Corp
NASDAQ:CLOV
|
Total Liabilities & Equity
$541m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
UnitedHealth Group Inc
NYSE:UNH
|
Total Liabilities & Equity
$309.6B
|
CAGR 3-Years
8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
|
|
Centene Corp
NYSE:CNC
|
Total Liabilities & Equity
$76.7B
|
CAGR 3-Years
0%
|
CAGR 5-Years
2%
|
CAGR 10-Years
26%
|
|
|
Molina Healthcare Inc
NYSE:MOH
|
Total Liabilities & Equity
$15.6B
|
CAGR 3-Years
8%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
|
Humana Inc
NYSE:HUM
|
Total Liabilities & Equity
$48.9B
|
CAGR 3-Years
4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
|
Elevance Health Inc
NYSE:ELV
|
Total Liabilities & Equity
$121.5B
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
Clover Health Investments Corp
Glance View
Clover Health Investments Corp. embarked on a mission to transform the healthcare landscape with its innovative approach as a next-generation Medicare Advantage insurer. Born out of the need to reduce inefficiencies and enhance care, Clover Health uses its proprietary technology platform, the Clover Assistant, to arm physicians with data-driven insights that facilitate informed decision-making at the point of care. By integrating technology with healthcare delivery, Clover targets not only the evident administrative wastage but also addresses the structural challenges faced by patients and providers alike. This unique integration of digital tools with a traditional insurance model sets Clover apart in an industry ripe for disruption. Revenue for Clover Health primarily comes from Medicare Advantage premiums, where it competes by offering cost-effective plans combined with improved service. The company augments its financial model through government reimbursements tied to patient outcomes and the quality of care. Central to this strategy is the effective use of data analytics to manage patient care, reduce medical costs, and improve customer satisfaction. This alignment of financial incentives—lowering costs while enhancing patient outcomes—fuels Clover’s growth narrative, positioning it as a key player in reshaping how Medicare Advantage operates at the intersection of technology and healthcare delivery.
See Also
What is Clover Health Investments Corp's Total Liabilities & Equity?
Total Liabilities & Equity
541m
USD
Based on the financial report for Dec 31, 2025, Clover Health Investments Corp's Total Liabilities & Equity amounts to 541m USD.
What is Clover Health Investments Corp's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
-9%
Over the last year, the Total Liabilities & Equity growth was -7%. The average annual Total Liabilities & Equity growth rates for Clover Health Investments Corp have been -13% over the past three years , -9% over the past five years .